Posterior Reversible Encephalopathy Syndrome During Treatment with Aflibercept, 5-Fluorouracil, Leucovorin, and Irinotecan for Metastatic Colorectal Cancer

被引：2
|
作者：
Miaris, Nikolaos [1 ]
Sgouros, Joseph [1 ]
Gerolympou, Margarita [1 ]
Spyropoulos, Basilios [2 ]
Drakopoulos, Dionysios [3 ]
Gkoura, Stefania [1 ]
Res, Helen [1 ]
Samantas, Epaminondas [1 ]
机构：
[1] Agioi Anargyroi Gen Oncol Hosp Kifisia, Dept Med Oncol 3, Noufaron & Timiou Stavrou 14, Athens 14564, Greece
[2] 401 Gen Mil Hosp Athens, Dept Internal Med 1, Athens, Greece
[3] 401 Gen Mil Hosp Athens, Dept Radiol, Athens, Greece
来源：
JOURNAL OF GASTROINTESTINAL CANCER | 2019年 / 50卷 / 01期
关键词：
LEUKOENCEPHALOPATHY SYNDROME; OXALIPLATIN;
D O I：
10.1007/s12029-017-9986-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：123 / 126
页数：4
相关论文
共 50 条
  • [21] Fluorouracil, leucovorin and irinotecan associated with aflibercept can induce microscopic colitis in metastatic colorectal cancer patients
    Ghiringhelli, Francois
    Vincent, Julie
    Beltjens, Francoise
    Bengrine, Leila
    Ladoire, Sylvain
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (06) : 1263 - 1266
  • [22] Fluorouracil, leucovorin and irinotecan associated with aflibercept can induce microscopic colitis in metastatic colorectal cancer patients
    François Ghiringhelli
    Julie Vincent
    Françoise Beltjens
    Leila Bengrine
    Sylvain Ladoire
    Investigational New Drugs, 2015, 33 : 1263 - 1266
  • [23] Combining bevacizumab and panitumumab with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as second-line treatment in patients with metastatic colorectal cancer
    Liang, Hong-Liang
    Hu, Ai-Ping
    Li, Sen-Lin
    Liu, Ji-Yong
    MEDICAL ONCOLOGY, 2014, 31 (06)
  • [24] Combining bevacizumab and panitumumab with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as second-line treatment in patients with metastatic colorectal cancer
    Hong-Liang Liang
    Ai-Ping Hu
    Sen-Lin Li
    Ji-Yong Liu
    Medical Oncology, 2014, 31
  • [25] Bimonthly leucovorin, infusion 5-fluorouracil, hydroxyurea, and irinotecan (FOLFIRI-2) for pretreated metastatic colorectal cancer
    Mabro, M
    Louvet, C
    André, T
    Carola, E
    Gilles-Amar, V
    Artru, P
    Krulik, M
    de Gramont, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (03): : 254 - 258
  • [26] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
    Hurwitz, H
    Fehrenbacher, L
    Novotny, W
    Cartwright, T
    Hainsworth, J
    Heim, W
    Berlin, J
    Baron, A
    Griffing, S
    Holmgren, E
    Ferrara, N
    Fyfe, G
    Rogers, B
    Ross, R
    Kabbinavar, F
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23): : 2335 - 2342
  • [27] Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.
    Saltz, LB
    Cox, JV
    Blanke, C
    Rosen, LS
    Fehrenbacher, L
    Moore, MJ
    Maroun, JA
    Ackland, SP
    Locker, PK
    Pirotta, N
    Elfring, GL
    Miller, LL
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (13): : 905 - 914
  • [28] Irinotecan/Fluorouracil/Leucovorin or the Same Regimen Followed by Oxaliplatin/Fluorouracil/Leucovorin in Metastatic Colorectal Cancer
    Kalofonos, Haralabos P.
    Papakostas, Pavlos
    Makatsoris, Thomas
    Papamichael, Demetrios
    Vourli, Georgia
    Xanthakis, Ioannis
    Aravantinos, Gerasimos
    Papadimitriou, Christos
    Pentheroudakis, George
    Varthalitis, Ioannis
    Samelis, George
    Syrigos, Kostas N.
    Xiros, Nikolaos
    Stavropoulos, Michalis
    Kosmidis, Paris
    Christodoulou, Christos
    Linardou, Helen
    Skondra, Maria
    Pectasides, Dimitrios
    Economopoulos, Theofanis
    Fountzilas, George
    ANTICANCER RESEARCH, 2010, 30 (10) : 4325 - 4333
  • [29] A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer
    M L Veronese
    W Sun
    B Giantonio
    J Berlin
    J Shults
    L Davis
    D G Haller
    P J O'Dwyer
    British Journal of Cancer, 2005, 92 : 1846 - 1849
  • [30] A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer
    Veronese, ML
    Sun, W
    Giantonio, B
    Berlin, J
    Shults, J
    Davis, L
    Haller, DG
    O'Dwyer, PJ
    BRITISH JOURNAL OF CANCER, 2005, 92 (10) : 1846 - 1849
12345